Therefore, in this study, we aimed to investigate the effects of liraglutide on endothelial dysfunction in LDL receptor-deficient mice and ox-LDL-challenged human umbilical vein endothelial cells (HUVECs) and to explore the role of GLP-1R and LOX-1 in this process. The gene discussed is GLP1R; the disease is endothelial dysfunction.